Routine upstream versus selective downstream administration of glycoprotein IIb/IIIa inhibitors in patients with non-ST-elevation acute coronary syndromes: A meta-analysis of randomized trials

Giuseppe Biondi-Zoccai, Enrico Romagnoli, Marco Valgimigli, Saman Rasoul, Arnoud van't Hof, Ernesto Lioy, Gregg W. Stone, Alessandro Sciahbasi
  • International Journal of Cardiology, March 2012, Elsevier
  • DOI: 10.1016/j.ijcard.2010.10.010
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Enrico Romagnoli, Professor Marco Valgimigli, and Dr Alessandro Sciahbasi